Research Summary Patient-derived xenograft (PDX) models are a type of preclinical research tool used in oncology and cancer research. These models involve transplanting tumor tissues or cells directly from cancer patients into immunodeficient mice or other animal models. PDX models aim to mimic the specific characteristics and behavior of a patient＇s tumor, allowing researchers to study its growth, response to treatments, and underlying biology in a controlled laboratory setting. PDX models are valuable for drug development and personalized medicine approaches, as they can help identify and test potential therapies and assess how an individual patient＇s cancer may respond to different treatments. These models bridge the gap between in vitro cell culture studies and human clinical trials, enabling researchers to make more informed decisions about treatment strategies and drug development based on a tumor＇s real-world behavior. According to DIResearch's in-depth investigation and research, the global Patient-derived Xenograft (PDX) Models market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%. The major global manufacturers of Patient-derived Xenograft (PDX) Models include Crown Bioscience, Champions Oncology, Wuxi Apptec, The Jackson Laboratory, EPO Berlin-Buch, Oncodesign, Xentech, Envigo, Charles River Laboratories, Pharmatest Services, Urosphere, MEDICILON, Horizon Discovery, Shanghai Model Organisms Center, GemPharmatech, LIDE Biotech etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale. This report studies the market size, price trends and future development prospects of Patient-derived Xenograft (PDX) Models. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Patient-derived Xenograft (PDX) Models market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030. The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Patient-derived Xenograft (PDX) Models market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Patient-derived Xenograft (PDX) Models industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy. The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database. Global Key Manufacturers of Patient-derived Xenograft (PDX) Models Include: Crown Bioscience Champions Oncology Wuxi Apptec The Jackson Laboratory EPO Berlin-Buch Oncodesign Xentech Envigo Charles River Laboratories Pharmatest Services Urosphere MEDICILON Horizon Discovery Shanghai Model Organisms Center GemPharmatech LIDE Biotech Patient-derived Xenograft (PDX) Models Product Segment Include: Mouse Model Rat Model Patient-derived Xenograft (PDX) Models Product Application Include: Preclinical Drug development Biomarker Analysis Chapter Scope Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends Chapter 2: Global Patient-derived Xenograft (PDX) Models Industry PESTEL Analysis Chapter 3: Global Patient-derived Xenograft (PDX) Models Industry Porter’s Five Forces Analysis Chapter 4: Global Patient-derived Xenograft (PDX) Models Major Regional Market Size and Forecast Analysis Chapter 5: Global Patient-derived Xenograft (PDX) Models Market Size and Forecast by Type and Application Analysis Chapter 6: North America Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 7: Europe Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 8: China Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 9: APAC (Excl. China) Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 10: Latin America Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 11: Middle East and Africa Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 12: Global Patient-derived Xenograft (PDX) Models Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration) Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin) Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers Chapter 15: Research Findings and Conclusion Chapter 16: Methodology and Data Sources
Table of Contents 1 Patient-derived Xenograft (PDX) Models Market Overview 1.1 Product Definition and Statistical Scope 1.2 Patient-derived Xenograft (PDX) Models Product by Type 1.2.1 Global Patient-derived Xenograft (PDX) Models Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Mouse Model 1.2.3 Rat Model 1.3 Patient-derived Xenograft (PDX) Models Product by Application 1.3.1 Global Patient-derived Xenograft (PDX) Models Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Preclinical Drug development 1.3.3 Biomarker Analysis 1.4 Global Patient-derived Xenograft (PDX) Models Market Revenue Analysis (2019-2030) 1.5 Patient-derived Xenograft (PDX) Models Market Development Status and Trends 1.5.1 Patient-derived Xenograft (PDX) Models Industry Development Status Analysis 1.5.2 Patient-derived Xenograft (PDX) Models Industry Development Trends Analysis 2 Patient-derived Xenograft (PDX) Models Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Patient-derived Xenograft (PDX) Models Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Patient-derived Xenograft (PDX) Models Market Analysis by Regions 4.1 Patient-derived Xenograft (PDX) Models Overall Market: 2023 VS 2024 VS 2030 4.2 Global Patient-derived Xenograft (PDX) Models Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Patient-derived Xenograft (PDX) Models Revenue and Market Share by Region (2019-2024) 4.2.2 Global Patient-derived Xenograft (PDX) Models Revenue Forecast by Region (2025-2030) 5 Global Patient-derived Xenograft (PDX) Models Market Size by Type and Application 5.1 Global Patient-derived Xenograft (PDX) Models Market Size by Type 5.2 Global Patient-derived Xenograft (PDX) Models Market Size by Application 6 North America 6.1 North America Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Patient-derived Xenograft (PDX) Models Market Size by Type 6.4 North America Patient-derived Xenograft (PDX) Models Market Size by Application 6.5 North America Patient-derived Xenograft (PDX) Models Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Patient-derived Xenograft (PDX) Models Market Size by Type 7.4 Europe Patient-derived Xenograft (PDX) Models Market Size by Application 7.5 Europe Patient-derived Xenograft (PDX) Models Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Patient-derived Xenograft (PDX) Models Market Size by Type 8.4 China Patient-derived Xenograft (PDX) Models Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size by Type 9.4 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size by Application 9.5 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Patient-derived Xenograft (PDX) Models Market Size by Type 10.4 Latin America Patient-derived Xenograft (PDX) Models Market Size by Application 10.5 Latin America Patient-derived Xenograft (PDX) Models Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Type 11.4 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Application 11.5 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Patient-derived Xenograft (PDX) Models Market Revenue by Key Manufacturers (2020-2024) 12.2 Patient-derived Xenograft (PDX) Models Competitive Landscape Analysis and Market Dynamic 12.2.1 Patient-derived Xenograft (PDX) Models Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Crown Bioscience 13.1.1 Crown Bioscience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Crown Bioscience Patient-derived Xenograft (PDX) Models Product Portfolio 13.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Champions Oncology 13.2.1 Champions Oncology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Champions Oncology Patient-derived Xenograft (PDX) Models Product Portfolio 13.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Wuxi Apptec 13.3.1 Wuxi Apptec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Portfolio 13.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 The Jackson Laboratory 13.4.1 The Jackson Laboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Portfolio 13.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 EPO Berlin-Buch 13.5.1 EPO Berlin-Buch Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Portfolio 13.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Oncodesign 13.6.1 Oncodesign Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Oncodesign Patient-derived Xenograft (PDX) Models Product Portfolio 13.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Xentech 13.7.1 Xentech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Xentech Patient-derived Xenograft (PDX) Models Product Portfolio 13.7.3 Xentech Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Envigo 13.8.1 Envigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Envigo Patient-derived Xenograft (PDX) Models Product Portfolio 13.8.3 Envigo Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Charles River Laboratories 13.9.1 Charles River Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Portfolio 13.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Pharmatest Services 13.10.1 Pharmatest Services Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Pharmatest Services Patient-derived Xenograft (PDX) Models Product Portfolio 13.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Urosphere 13.11.1 Urosphere Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Urosphere Patient-derived Xenograft (PDX) Models Product Portfolio 13.11.3 Urosphere Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 MEDICILON 13.12.1 MEDICILON Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 MEDICILON Patient-derived Xenograft (PDX) Models Product Portfolio 13.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.13 Horizon Discovery 13.13.1 Horizon Discovery Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Horizon Discovery Patient-derived Xenograft (PDX) Models Product Portfolio 13.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.14 Shanghai Model Organisms Center 13.14.1 Shanghai Model Organisms Center Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product Portfolio 13.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.15 GemPharmatech 13.15.1 GemPharmatech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.15.2 GemPharmatech Patient-derived Xenograft (PDX) Models Product Portfolio 13.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.16 LIDE Biotech 13.16.1 LIDE Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.16.2 LIDE Biotech Patient-derived Xenograft (PDX) Models Product Portfolio 13.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Patient-derived Xenograft (PDX) Models Industry Chain Analysis 14.2 Patient-derived Xenograft (PDX) Models Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Patient-derived Xenograft (PDX) Models Typical Downstream Customers 14.4 Patient-derived Xenograft (PDX) Models Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook